scispace - formally typeset
Y

Yves Pommier

Researcher at National Institutes of Health

Publications -  847
Citations -  65543

Yves Pommier is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Topoisomerase & DNA. The author has an hindex of 123, co-authored 789 publications receiving 58898 citations. Previous affiliations of Yves Pommier include Purdue University & Kyushu University.

Papers
More filters
Journal ArticleDOI

Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.

TL;DR: A hydroxyethylaminopropyl side chain on the lactam nitrogen of two halogenated indenoisoquinoline Top1 inhibitors was found to also impart inhibitory activity against tyrosyl DNA phosphodiesterases 1 and 2 (TDP1 and TDP2), which are enzymes that participate in the repair of DNA damage induced by Top1 poisons.
Journal ArticleDOI

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications

TL;DR: The most recent advances in the field of genetics are presented, including the new genetic insights of PPGLs and the latest guidelines on the surveillance of asymptomatic SDHx mutation carriers.
Journal ArticleDOI

The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.

TL;DR: Eight novel series of A-ring-substituted aromathecins are synthesized, through a simple, modular route, as part of a comprehensive SAR study, and this considerable SAR overlap lends further support to the hypothesis that aromathcins bind in the Top1 cleavage complex as interfacial inhibitors in a 'camptothecin-like' pose.